35 related articles for article (PubMed ID: 24940683)
21. Targeting platelet-derived endothelial cell growth factor/thymidine phosphorylase for cancer therapy.
Liekens S; Bronckaers A; Pérez-Pérez MJ; Balzarini J
Biochem Pharmacol; 2007 Dec; 74(11):1555-67. PubMed ID: 17572389
[TBL] [Abstract][Full Text] [Related]
22. Recent advances in the synthetic thymidine phosphorylase inhibitors for cancer therapy.
Feng Q; Yang W; Peng Z; Wang G
Eur J Pharmacol; 2022 Nov; 934():175319. PubMed ID: 36220359
[TBL] [Abstract][Full Text] [Related]
23. Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment.
Toi M; Atiqur Rahman M; Bando H; Chow LW
Lancet Oncol; 2005 Mar; 6(3):158-66. PubMed ID: 15737832
[TBL] [Abstract][Full Text] [Related]
24. A kinetic, modeling and mechanistic re-analysis of thymidine phosphorylase and some related enzymes.
Edwards PN
J Enzyme Inhib Med Chem; 2006 Oct; 21(5):483-99. PubMed ID: 17194017
[TBL] [Abstract][Full Text] [Related]
25. Mycoplasmas and cancer: focus on nucleoside metabolism.
Vande Voorde J; Balzarini J; Liekens S
EXCLI J; 2014; 13():300-22. PubMed ID: 26417262
[TBL] [Abstract][Full Text] [Related]
26. Mycoplasma pneumoniae thymidine phosphorylase.
Wang L; Schmidl SR; Stülke J
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):296-304. PubMed ID: 24940683
[TBL] [Abstract][Full Text] [Related]
27. Recent discovery of non-nucleobase thymidine phosphorylase inhibitors targeting cancer.
Bera H; Chigurupati S
Eur J Med Chem; 2016 Nov; 124():992-1003. PubMed ID: 27783978
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a disease of two genomes.
Hirano M; Nishigaki Y; Martí R
Neurologist; 2004 Jan; 10(1):8-17. PubMed ID: 14720311
[TBL] [Abstract][Full Text] [Related]
29. Multifunctional role of thymidine phosphorylase in cancer.
Warfield BM; Reigan P
Trends Cancer; 2022 Jun; 8(6):482-493. PubMed ID: 35193822
[TBL] [Abstract][Full Text] [Related]
30. Thymidine phosphorylase in cancer aggressiveness and chemoresistance.
Furukawa T; Tabata S; Yamamoto M; Kawahara K; Shinsato Y; Minami K; Shimokawa M; Akiyama SI
Pharmacol Res; 2018 Jun; 132():15-20. PubMed ID: 29604437
[TBL] [Abstract][Full Text] [Related]
31. Thymidine phosphorylase and breast carcinoma.
Yang Q; Yoshimura G; Mori I; Sakurai T; Kakudo K
Anticancer Res; 2002; 22(4):2355-60. PubMed ID: 12174926
[TBL] [Abstract][Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
